FDA update

law and order concept
Pharma

FDA orders GLP-1s add eye risk to labels

The FDA is ordering drugmakers to add a new and rare eye risk to the labels of 12 GLP-1s, including Zepbound and Ozempic.
Donavyn Coffey Nov 10, 2026 8:31am